Mitochondrial routing of glucose and sucrose polymers after pinocytotic uptake: Avenues for drug delivery

Biomacromolecules

Volumn 15, Issue 6, 2014, Pages 2119-2127

  Rashid, Rafi ^a,b,c,f   Beyer, Sebastian ^a,c,g   Blocki, Anna ^a,c,h   Le Visage, Catherine ^d   Trau, Dieter ^c   Wohland, Thorsten ^b,c   Raghunath, Michael ^c,e  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d INSERM   (France)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^g SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^h AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; DRUG DELIVERY; POLYMERS; SUGAR (SUCROSE);

CLINICAL FEASIBILITY; INTRACELLULAR LEVELS; LOW MOLECULAR WEIGHT; MESENCHYMAL STEM CELL; MITOCHONDRIAL DYSFUNCTION; MULTIDRUG RESISTANCE; POLYMERIC CARRIERS; TARGETED DRUG DELIVERY;

MITOCHONDRIA;

FICOLL; GLUCOSE POLYMER; ROSE BENGAL; GLUCOSE; POLYMER; SUCROSE;

ARTICLE; CELL CULTURE; CELL PROLIFERATION ASSAY; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; HUMAN CELL; LYSOSOME; MESENCHYMAL STEM CELL; MITOCHONDRION; MULTIDRUG RESISTANCE; PINOCYTOSIS; POLYMERIZATION; PRIORITY JOURNAL; CELL SURVIVAL; DRUG EFFECTS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; PROCEDURES;

CELL SURVIVAL; DRUG DELIVERY SYSTEMS; GLUCOSE; HUMANS; MESENCHYMAL STROMAL CELLS; MITOCHONDRIA; PINOCYTOSIS; POLYMERS; SUCROSE;

EID: 84902191486     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm500243m     Document Type: Article

References (44)

1. Beal, M. Mitochondrial dysfunction in neurodegenerative diseases Biochim. Biophys. Acta 1998, 1366, 211-223
2. Modica-Napolitano, J.; Singh, K. Mitochondrial dysfunction in cancer Mitochondrion 2004, 4, 755-762
3. Ballinger, S. Mitochondrial dysfunction in cardiovascular disease Free Radical Biol. Med. 2005, 38, 1278-1295
4. Lowell, B.; Shulman, G. Mitochondrial dysfunction and type 2 diabetes Science 2005, 307, 384-387
5. Adlam, V.; Harrison, J.; Porteous, C.; James, A.; Smith, R.; Murphy, M.; Sammut, I. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury FASEB J. 2005, 19, 1088-1095
6. Sheu, S.; Nauduri, D.; Anders, M. Targeting antioxidants to mitochondria: a new therapeutic direction Biochim. Biophys. Acta 2006, 1762, 256-265
7. Muratovska, A.; Lightowlers, R.; Taylor, R.; Turnbull, D.; Smith, R.; Wilce, J.; Martin, S.; Murphy, M. Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease Nucleic Acids Res. 2001, 29, 1852-1863
8. Theodossiou, T.; Sideratou, Z.; Tsiourvas, D.; Paleos, C. A novel mitotropic oligolysine nanocarrier: Targeted delivery of covalently bound D-Luciferin to cell mitochondria Mitochondrion 2011, 11, 982-986
9. Marrache, S.; Dhar, S. Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 16288-16293
10. Weissig, V. From serendipity to mitochondria-targeted nanocarriers Pharm. Res. 2011, 28, 2657-2668
11. D'Souza, G.; Rammohan, R.; Cheng, S.; Torchilin, V.; Weissig, V. DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells J. Controlled Release 2003, 19, 189-197
12. Breunig, M.; Bauer, S.; Goepferich, A. Polymers and nanoparticles: intelligent tools for intracellular targeting? Eur. J. Pharm. Biopharm. 2008, 68, 112-128
13. Hoshino, A.; Fujioka, K.; Oku, T.; Nakamura, S.; Suga, M.; Yamaguchi, Y.; Suzuki, K.; Yasuhara, M.; Yamamoto, K. Quantum dots targeted to the assigned organelle in living cells Microbiol. Immunol. 2004, 48, 985-994
14. Delehanty, J.; Blanco-Canosa, J.; Bradburne, C.; Susumu, K.; Stewart, M.; Prasuhn, D.; Dawson, P.; Medintz, I. Site-specific cellular delivery of quantum dots with chemoselectively-assembled modular peptides Chem. Commun. (Cambridge, U.K.) 2013, 49, 7878-7880
15. Albanese, A.; Tang, P.; Chan, W. The effect of nanoparticle size, shape, and surface chemistry on biological systems Annu. Rev. Biomed. Eng. 2012, 14, 1-16
16. Venturoli, D.; Rippe, B. Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability Am. J. Physiol.: Renal, Fluid Electrolyte Physiol. 2005, 288, F605-F613
17. Harada, M.; Aoyagi, N.; Kondo, K.; Ishino, C.; Odaka, K.; Matsue, K.; Yoshida, T.; Hattori, K. Allogeneic bone marrow transplantation from a major ABO-incompatible donor. Infusion of hemopoietic stem cells isolated by Ficoll-Hypaque method Transplantation 1983, 35, 191-192
18. File # K092107. www.fda.gov (accessed April 9, 2014).
19. Lareu, R. R.; Subramhanya, K. H.; Peng, Y.; Benny, P.; Chen, C.; Wang, Z.; Rajagopalan, R.; Raghunath, M. Collagen matrix deposition is dramatically enhanced in vitro when crowded with charged macromolecules: the biological relevance of the excluded volume effect FEBS Lett. 2007, 581 (14) 2709-2714
20. Lareu, R. R.; Arsianti, I.; Subramhanya, H. K.; Yanxian, P.; Raghunath, M. In vitro enhancement of collagen matrix formation and crosslinking for applications in tissue engineering: a preliminary study Tissue Eng. 2007, 13 (2) 385-391
21. Chen, C.; Loe, F.; Blocki, A.; Peng, Y.; Raghunath, M. Applying macromolecular crowding to enhance extracellular matrix deposition and its remodeling in vitro for tissue engineering and cell-based therapies Adv. Drug Delivery Rev. 2011, 63 (4-5) 277-290
22. Zeiger, A.; Loe, F.; Li, R.; Raghunath, M.; van Vliet, K. Macromolecular crowding directs extracellular matrix organization and mesenchymal stem cell behavior PLoS One 2012, 7, e37904
23. Ang, X.; Lee, M.; Blocki, A.; Chen, C.; Ong, L.; Asada, H.; Sheppard, A.; Raghunath, M. Macromolecular crowding amplifies adipogenesis of human bone marrow-derived MSCs by enhancing the pro-adipogenic environment Tissue Eng., Part A 2014, 20 (5-6) 966-981
24. Dunn, P.; Kuo, T.; Shih, L. Y.; Wang, P. N.; Sun, C. F.; Chang, M. J. Bone marrow failure and myelofibrosis in a case of PVP storage disease Am. J. Hematol. 1998, 57, 68-71
25. Huang, W.; Chang, C.; Tsai, C. Polyvinylpyrrolidone storage disease presenting as pathologic fracture and anemia: report of a case with imprint cytology Diagn. Cytopathol. 2012, 40, 69-72
26. Rashid, R.; Lim, N.; Chee, S.; Png, S.; Wohland, T.; Raghunath, M. Novel use for polyvinylpyrrolidone as a macromolecular crowder for enhanced extracellular matrix deposition and cell proliferation Tissue Eng., Part C 2014, 0.1089/ten.tec.2013.0733
27. Panzarini, E.; Inguscio, V.; Dini, L. Timing the multiple cell death pathways initiated by Rose Bengal acetate photodynamic therapy Cell Death Dis. 2011, 2, e169
28. de Belder, A.; Granath, K. Preparation and properties of fluorescein-labelled dextrans Carbohydr. Res. 1973, 30, 375-378
29. Armstrong, J.; Wenby, R.; Meiselman, H.; Fisher, T. The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation Biophys. J. 2004, 87, 4259-4270
30. Nishinari, K.; Kohyama, K.; Williams, P.; Phillips, G.; Burchard, W.; Ogina, K. Solution properties of pullulan Macromolecules 1991, 24, 5590-5593
31. Kapoor, R.; Jain, M.; Mishra, V. Fluorescence and absorption spectra of Rose Bengal dye in the presence of surfactants J. Lumin. 1981, 22, 429-439
32. Thirion, J.; Wattiaux, R. Effect of monensin on fluid phase and receptor mediated endocytosis by rat hepatocyte monolayers Biochem. Biophys. Res. Commun. 1988, 152, 1275-1281
33. Chen, X.; Wang, Z. Regulation of epidermal growth factor receptor endocytosis by wortmannin through activation of Rab5 rather than inhibition of phosphatidylinositol 3-kinase EMBO Rep. 2001, 2, 842-849
34. Theodossiou, T.; Sideratou, Z.; Katsarou, M.; Tsiourvas, D. Mitochondria delivery of doxorubicin by triphenylphosphonium-functionalized hyperbranched nanocarriers results in rapid and severe cytotoxicity Pharm. Res. 2013, 30, 2832-2842
35. Thompson, J.; Hersey, P.; Wachter, E. Chemoablation of metastatic melanoma using intralesional Rose Bengal Melanoma Res. 2008, 18, 405-411
36. Tan, C.; Neuhaus, S. Novel use of Rose Bengal (PV-10) in two cases of refractory scalp sarcoma Aust. N. Z. J. Surg. 2013, 83, 93
37. Martin, J. J.; Burch, P. Production of oxygen radicals by photosensitization Methods Enzymol. 1990, 186, 635-645
38. Halliwell, B.; Gutteridge, J. Free Radicals in Biology and Medicine; Clarendon: Oxford, U.K., 1985.
39. Cunningham, M.; Krinksy, N.; Giovanazzi, S.; Peak, M. J. Superoxide anion is generated from cellular metabolites by solar radiation and its components Free Radical Biol. Med. 1985, 1, 381-385
40. Maeda, K.; Iseki, S.; Urushibata, I.; Uesugi, Y.; Sato, S. 2 cases of PVP storage disease Naika 1966, 17, 159-166
41. Ficoll PM 70, Ficoll PM 400; GE Healthcare Bio-Sciences and Amersham Biosciences AB: Uppsala, Sweden, 2007; pp 1-6.
42. Kato, I. Fragrance J. 2005, 33, 59-64
43. Mehvar, R. Dextrans for targeted and sustained delivery of therapeutic and imaging agents J. Controlled Release 2000, 69, 1-25
44. Ting, S. R.; Gregory, A. M.; Stenzel, M. H. Polygalactose containing nanocages: the RAFT process for the synthesis of hollow sugar balls Biomacromolecules 2009, 10, 342-352